CLOS
RPTX

Compagnie Lombard Odier SCmA’s Repare Therapeutics RPTX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,000
Closed -$18.3K – 491
2024
Q4 		$18.3K Hold
14,000
– – ﹤0.01% 394
2024
Q3 		$48.2K Hold
14,000
– – ﹤0.01% 342
2024
Q2 		$46.2K Hold
14,000
– – ﹤0.01% 337
2024
Q1 		$65.9K Hold
14,000
– – ﹤0.01% 331
2023
Q4 		$102K Hold
14,000
– – ﹤0.01% 351
2023
Q3 		$169K Hold
14,000
– – ﹤0.01% 296
2023
Q2 		$148K Hold
14,000
– – ﹤0.01% 311
2023
Q1 		$140K Buy
+14,000
New +$161K ﹤0.01% 344

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Compagnie Lombard Odier SCmA's RPTX Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of Repare Therapeutics (RPTX) in Q1 2025, closing a stake of 14,000 shares — an estimated $18.3K sold.

Compagnie Lombard Odier SCmA first reported a position in RPTX in Q1 2023 and held it in 8 quarters. The position peaked at $169K in Q3 2023. 50 funds tracked by Wall St. Rank hold RPTX as of Q1 2025.

  • Compagnie Lombard Odier SCmA reported no remaining Repare Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 14,000 Repare Therapeutics shares in Q1 2025, an estimated $18.3K.
  • Compagnie Lombard Odier SCmA first reported a position in Repare Therapeutics in Q1 2023 and held it in 8 quarters.
  • Compagnie Lombard Odier SCmA's Repare Therapeutics position peaked at $169K in Q3 2023.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.